The Atlantic will break down the latest in immunotherapy and how it is being used to help young patients survive and thrive. And moving beyond anecdotal evidence, we'll examine how can big data can be used to track how pediatric cancers impact aspects of health for survivors down the road.
The Atlantic will convene top health policy thinkers and practitioners to explore how to foster drug innovation while controlling cost with new approaches like value-based programs on the horizon.
The Atlantic convened key stakeholders to discuss the state of and future for biosimilars.
The Atlantic gathered key stakeholders to examine the future for biosimilars domestically and abroad.